• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤坏死因子:一种由活化巨噬细胞杀死肿瘤细胞的强效效应分子。

Tumor necrosis factor: a potent effector molecule for tumor cell killing by activated macrophages.

作者信息

Urban J L, Shepard H M, Rothstein J L, Sugarman B J, Schreiber H

出版信息

Proc Natl Acad Sci U S A. 1986 Jul;83(14):5233-7. doi: 10.1073/pnas.83.14.5233.

DOI:10.1073/pnas.83.14.5233
PMID:3487788
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC323925/
Abstract

Activated macrophages (aM phi) destroy more effectively cancer cells than normal cells. The mechanism by which macrophages destroy cancer cells is not known. We report here that tumor cells susceptible to aM phi were killed by recombinant (r) tumor necrosis factor type alpha (TNF-alpha), whereas variant tumor cells resistant to aM phi after selection in vitro or in vivo were resistant to killing by rTNF-alpha. The converse selection for rTNF-alpha-resistant variants resulted in cells that were also resistant to killing by aM phi. The sensitivity of macrophage-resistant variants was not changed to other tumoricidal cells or soluble mediators, except that the macrophage-resistant variants were also resistant to the effects of another cytotoxic protein, B-cell lymphotoxin, which is structurally related to rTNF-alpha. Similar results were obtained regardless of whether short-term or long-term cytotoxic effects of aM phi were measured. Finally, it was shown that killing of tumor cells by murine aM phi was completely inhibited with a polyclonal antibody that neutralizes the effects of murine TNF-alpha. These results suggest a major role for TNF-alpha in tumor cell destruction by aM phi in vitro and in vivo.

摘要

活化巨噬细胞(aM phi)对癌细胞的破坏作用比正常细胞更有效。巨噬细胞破坏癌细胞的机制尚不清楚。我们在此报告,对aM phi敏感的肿瘤细胞可被重组(r)肿瘤坏死因子α(TNF-α)杀死,而在体外或体内筛选后对aM phi具有抗性的变异肿瘤细胞对rTNF-α的杀伤具有抗性。对rTNF-α抗性变异体进行反向筛选得到的细胞对aM phi的杀伤也具有抗性。除了巨噬细胞抗性变异体对另一种细胞毒性蛋白B细胞淋巴毒素的作用也具有抗性(B细胞淋巴毒素在结构上与rTNF-α相关)外,巨噬细胞抗性变异体对其他杀肿瘤细胞或可溶性介质的敏感性未发生改变。无论测量的是aM phi的短期还是长期细胞毒性作用,均可获得类似结果。最后,结果表明,用一种中和鼠TNF-α作用的多克隆抗体可完全抑制鼠aM phi对肿瘤细胞的杀伤。这些结果表明TNF-α在体外和体内aM phi对肿瘤细胞的破坏中起主要作用。

相似文献

1
Tumor necrosis factor: a potent effector molecule for tumor cell killing by activated macrophages.肿瘤坏死因子:一种由活化巨噬细胞杀死肿瘤细胞的强效效应分子。
Proc Natl Acad Sci U S A. 1986 Jul;83(14):5233-7. doi: 10.1073/pnas.83.14.5233.
2
Interferon gamma and lymphotoxin or tumor necrosis factor act synergistically to induce macrophage killing of tumor cells and schistosomula of Schistosoma mansoni.γ干扰素与淋巴毒素或肿瘤坏死因子协同作用,诱导巨噬细胞杀伤肿瘤细胞和曼氏血吸虫的童虫。
J Exp Med. 1987 Aug 1;166(2):589-94. doi: 10.1084/jem.166.2.589.
3
[Experimental analysis of cytotoxicity mediated by activated macrophages against glioma cells in mice].
Nihon Geka Hokan. 1993 Mar 1;62(2):92-115.
4
Separation of soluble amoebicidal and tumoricidal activity of activated macrophages.
J Protozool. 1992 Jan-Feb;39(1):235-41. doi: 10.1111/j.1550-7408.1992.tb01307.x.
5
Recombinant human tumor necrosis factor-alpha: evidence of an indirect mode of antitumor activity.重组人肿瘤坏死因子-α:抗肿瘤活性间接模式的证据
Cancer Res. 1987 Jul 15;47(14):3707-11.
6
Production of tumor necrosis factor by rIFN-gamma-primed C3H/HeJ (Lpsd) macrophages requires the presence of lipid A-associated proteins.经重组干扰素-γ预处理的C3H/HeJ(Lpsd)巨噬细胞产生肿瘤坏死因子需要脂多糖相关蛋白的存在。
J Immunol. 1988 Dec 15;141(12):4196-202.
7
Macrophage-mediated cytotoxicity: role of a soluble macrophage cytotoxic factor similar to lymphotoxin and tumor necrosis factor.巨噬细胞介导的细胞毒性:一种类似于淋巴毒素和肿瘤坏死因子的可溶性巨噬细胞细胞毒性因子的作用
Proc Natl Acad Sci U S A. 1983 Oct;80(20):6341-5. doi: 10.1073/pnas.80.20.6341.
8
Tumor necrosis factor, alone or in combination with IL-2, but not IFN-gamma, is associated with macrophage killing of Mycobacterium avium complex.肿瘤坏死因子单独或与白细胞介素-2联合使用时(而非与γ干扰素联合使用),与巨噬细胞杀灭鸟分枝杆菌复合体有关。
J Immunol. 1988 May 1;140(9):3006-13.
9
Characterization of 3LL-tumor variants generated by in vitro macrophage-mediated selection.
Int J Cancer. 1987 Mar 15;39(3):343-52. doi: 10.1002/ijc.2910390313.
10
TPA induction of EL4 resistance to macrophage-released TNF: role of ADP-ribosylation in tumoricidal activities of TNF and other factors.
Cell Immunol. 1990 Apr 15;127(1):78-91. doi: 10.1016/0008-8749(90)90116-9.

引用本文的文献

1
Functional RNAi Screening Identifies G2/M and Kinetochore Components as Modulators of TNFα/NF-κB Prosurvival Signaling in Head and Neck Squamous Cell Carcinoma.功能性 RNAi 筛选鉴定出 G2/M 和着丝粒组件作为 TNFα/NF-κB 生存信号在头颈部鳞状细胞癌中的调节剂。
Cancer Res Commun. 2024 Nov 1;4(11):2903-2918. doi: 10.1158/2767-9764.CRC-24-0274.
2
Trastuzumab: dreams, desperation and hope.曲妥珠单抗:梦想、绝望与希望。
Nat Rev Cancer. 2024 May;24(5):287-288. doi: 10.1038/s41568-024-00676-9.
3
Macrophages maintain mammary stem cell activity and mammary homeostasis via TNF-α-PI3K-Cdk1/Cyclin B1 axis.巨噬细胞通过肿瘤坏死因子-α-磷脂酰肌醇-3-激酶-细胞周期蛋白依赖性激酶1/细胞周期蛋白B1轴维持乳腺干细胞活性和乳腺内环境稳定。
NPJ Regen Med. 2023 May 2;8(1):23. doi: 10.1038/s41536-023-00296-1.
4
Inhibition of USP14 promotes TNFα-induced cell death in head and neck squamous cell carcinoma (HNSCC).USP14 抑制促进头颈部鳞状细胞癌(HNSCC)中 TNFα 诱导的细胞死亡。
Cell Death Differ. 2023 May;30(5):1382-1396. doi: 10.1038/s41418-023-01144-x. Epub 2023 Apr 13.
5
Multiplex Immunofluorescence and the Digital Image Analysis Workflow for Evaluation of the Tumor Immune Environment in Translational Research.用于转化研究中肿瘤免疫环境评估的多重免疫荧光及数字图像分析工作流程
Front Oncol. 2022 Jun 27;12:889886. doi: 10.3389/fonc.2022.889886. eCollection 2022.
6
Inhibiting WEE1 and IKK-RELA Crosstalk Overcomes TNFα Resistance in Head and Neck Cancers.抑制 WEE1 和 IKK-RELA 串扰克服头颈部癌症中 TNFα 的耐药性。
Mol Cancer Res. 2022 Jun 3;20(6):867-882. doi: 10.1158/1541-7786.MCR-21-0624.
7
Antioxidative and Immunomodulatory Potential of the Endemic French Guiana Wild Cocoa "Guiana".法属圭亚那特有野生可可“圭亚那”的抗氧化和免疫调节潜力
Foods. 2021 Mar 3;10(3):522. doi: 10.3390/foods10030522.
8
The Tumor Microenvironment: A Milieu Hindering and Obstructing Antitumor Immune Responses.肿瘤微环境:阻碍抗肿瘤免疫反应的环境。
Front Immunol. 2020 May 15;11:940. doi: 10.3389/fimmu.2020.00940. eCollection 2020.
9
The expanding landscape of inflammatory cells affecting cancer therapy.影响癌症治疗的炎症细胞的扩展领域。
Nat Biomed Eng. 2020 May;4(5):489-498. doi: 10.1038/s41551-020-0524-y. Epub 2020 Mar 18.
10
Tumor heterogeneity and clonal cooperation influence the immune selection of IFN-γ-signaling mutant cancer cells.肿瘤异质性和克隆合作影响 IFN-γ 信号突变癌细胞的免疫选择。
Nat Commun. 2020 Jan 30;11(1):602. doi: 10.1038/s41467-020-14290-4.

本文引用的文献

1
Macrophage activation for tumor cytotoxicity: characterization of priming and trigger signals during lymphokine activation.巨噬细胞激活以实现肿瘤细胞毒性:淋巴因子激活过程中启动信号和触发信号的特征
J Immunol. 1981 Jul;127(1):179-83.
2
Activation of mouse macrophages for tumor cell killing. I. Quantitative analysis of interactions between lymphokine and lipopolysaccharide.激活小鼠巨噬细胞以杀伤肿瘤细胞。I. 淋巴因子与脂多糖相互作用的定量分析。
J Immunol. 1981 May;126(5):1863-7.
3
Effector mechanisms of cytolytically activated macrophages. I. Secretion of neutral proteases and effect of protease inhibitors.溶细胞活化巨噬细胞的效应机制。I. 中性蛋白酶的分泌及蛋白酶抑制剂的作用
J Immunol. 1980 Jan;124(1):286-92.
4
Mechanisms of syngeneic tumor rejection. Susceptibility of host-selected progressor variants to various immunological effector cells.同基因肿瘤排斥的机制。宿主选择的进展性变体对各种免疫效应细胞的敏感性。
J Exp Med. 1982 Feb 1;155(2):557-73. doi: 10.1084/jem.155.2.557.
5
Malignant growth in the normal host after variant selection in vitro with cytolytic T-cell lines.在体外使用细胞溶解性T细胞系进行变体选择后,正常宿主体内出现恶性生长。
Proc Natl Acad Sci U S A. 1984 Apr;81(7):2186-90. doi: 10.1073/pnas.81.7.2186.
6
Human lymphotoxin. Production by a lymphoblastoid cell line, purification, and initial characterization.人淋巴毒素。由淋巴母细胞系产生、纯化及初步特性鉴定。
J Biol Chem. 1984 Jan 10;259(1):686-91.
7
Macrophage-mediated cytotoxicity: role of a soluble macrophage cytotoxic factor similar to lymphotoxin and tumor necrosis factor.巨噬细胞介导的细胞毒性:一种类似于淋巴毒素和肿瘤坏死因子的可溶性巨噬细胞细胞毒性因子的作用
Proc Natl Acad Sci U S A. 1983 Oct;80(20):6341-5. doi: 10.1073/pnas.80.20.6341.
8
Multiple tumour-specific antigens expressed on a single tumour cell.单个肿瘤细胞上表达多种肿瘤特异性抗原。
Nature. 1983;304(5922):165-7. doi: 10.1038/304165a0.
9
Immunologic mechanisms in UV radiation carcinogenesis.紫外线辐射致癌中的免疫机制。
Adv Cancer Res. 1981;34:69-106. doi: 10.1016/s0065-230x(08)60239-0.
10
Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin.人肿瘤坏死因子:前体结构、表达及其与淋巴毒素的同源性。
Nature. 1984;312(5996):724-9. doi: 10.1038/312724a0.